CompaniesLifordi Immunotherapeutics
Lifordi Immunotherapeutics logo

Lifordi Immunotherapeutics

active
Burlington, MA, United States
Founded 2023
Website
About

ADC-based delivery platform

Areas of Focus

Categories

Biologics & BiopharmaceuticalAntibodyBoston & New England
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

176

By Phase

PHASE1: 1

By Status

NOT_YET_RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2024
2025
2026
2027
2028
Today
NCT07207954
Hover over trial bars to see details

Recent Trials

NCT07207954Lead Sponsor
Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis
PHASE1Not yet recruiting
176 participants
Started: Oct 6, 2025 · Completed: Jul 16, 2027
Locations (1)
Headquarters
Burlington, MA, United States
Map

Loading map...